Pediatric skull inflammatory myofibroblastic tumor: a rare case report and literature review

Eeshan Khurana,Shaan Mody,Tanisha Shah,John-Paul Bouffard,Maria Pedemonte,Gianna Holover,Jessica S Lee,Gregg Jacob,Sara Scheid,Robert Morin,Catherine Mazzola
DOI: https://doi.org/10.1007/s00381-024-06512-7
2024-06-25
Abstract:Inflammatory myofibroblastic tumors (IMTs) represent rare neoplasms, particularly infrequent in the pediatric skull. We present a novel case of a newborn male with a 5 cm right temporal mass and discuss current diagnostic and treatment options for IMTs. A multidisciplinary effort to surgically remove the lesion was successful, and the patient's skull defect healed without neurological deficits. The etiology of IMTs remains elusive, with proposed associations with chromosomal mutations in the anaplastic lymphoma kinase (ALK) gene. Surgical excision remains the primary treatment for IMTs. Promising pharmacological treatments, like Crizotinib, warrant further research into understanding potential alternatives in IMT management.
What problem does this paper attempt to address?